scholarly journals Antimicrobial susceptibility testing of historical and recent clinical isolates of Bordetella pertussis in the United Kingdom using the Etest method

2010 ◽  
Vol 29 (9) ◽  
pp. 1183-1185 ◽  
Author(s):  
N. K. Fry ◽  
J. Duncan ◽  
L. Vaghji ◽  
R. C. George ◽  
T. G. Harrison
Keyword(s):  
United Kingdom ◽  
Bordetella Pertussis ◽  
Antimicrobial Susceptibility ◽  
Susceptibility Testing ◽  
Antimicrobial Susceptibility Testing ◽  
Clinical Isolates ◽  
The United Kingdom

scholarly journals Antimicrobial Susceptibility Testing of Clinical Isolates of Bordetella pertussis from Northern California: Report from the SENTRY Antimicrobial Surveillance Program

2001 ◽  
Vol 45 (12) ◽  
pp. 3599-3600 ◽  
Author(s):  
Kelley A. Gordon ◽  
Judy Fusco ◽  
Douglas J. Biedenbach ◽  
Michael A. Pfaller ◽  
Ronald N. Jones
Keyword(s):  
Bordetella Pertussis ◽  
Antimicrobial Susceptibility ◽  
Antimicrobial Agents ◽  
Susceptibility Testing ◽  
Antimicrobial Susceptibility Testing ◽  
Clinical Isolates ◽  
Surveillance Program ◽  
Northern California ◽  
Development Of Resistance ◽  
Antimicrobial Surveillance

ABSTRACT Reports of an increased clinical incidence of pertussis and the development of resistance by Bordetella pertussis to erythromycin prompted the collection and testing of recent clinical isolates from patients in northern California against a range of antimicrobial agents by the Etest (AB BIODISK, Solna, Sweden) method. All isolates were fully susceptible to all eight agents tested (MIC, ≤0.38 μg/ml), including newer fluoroquinolones, such as gatifloxacin (MIC of which 90% of the isolates tested are inhibited, 0.006 μg/ml), which may be used in cases of adolescent or adult pertussis. Continued surveillance of B. pertussis isolates appears to be a prudent practice.

Sign in / Sign up

Export Citation Format

Share Document